(Q42510389)

1 November 2017

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women (English)

1 reference

1 November 2017

12

I O Ellis

1 reference

1 November 2017

10

E A Rakha

1 reference

1 November 2017

A J Agboola

1

1 reference

1 November 2017

A A Musa

2

1 reference

1 November 2017

N Wanangwa

3

1 reference

1 November 2017

T Abdel-Fatah

4

1 reference

1 November 2017

C C Nolan

5

1 reference

1 November 2017

B A Ayoade

6

1 reference

1 November 2017

T Y Oyebadejo

7

1 reference

1 November 2017

A A Banjo

8

1 reference

1 November 2017

A M Deji-Agboola

9

1 reference

1 November 2017

A R Green

11

1 reference

1 November 2017

language of work or name

English

0 references

publication date

29 July 2012

1 reference

Breast Cancer Research and Treatment

1 November 2017

1 reference

1 November 2017

135

1 reference

1 November 2017

2

1 reference

1 November 2017

555-569

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-2173-7

1 November 2017

0 references

cites work

The global breast cancer burden: variations in epidemiology and survival.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Breast cancer in African-American women: differences in tumor biology from European-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Trends in breast cancer by race and ethnicity: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

The changing global patterns of female breast cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Early onset of breast cancer in a group of British black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Multistep carcinogenesis of breast cancer and tumour heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

The ethnic profile of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Education and income differentials in breast and cervical cancer screening. Policy implications for rural women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Socioeconomic status and breast cancer incidence in California for different race/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Are patients diagnosed with breast cancer before age 50 years ever cured?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Breast cancer prognostic classification in the molecular era: the role of histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Immunohistochemical and molecular subtypes of breast cancer in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

The severity, outcome and challenges of breast cancer in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Knowledge of breast cancer and its early detection measures among rural women in Akinyele Local Government Area, Ibadan, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

A comparison of the pattern of occurrence of breast cancer in Nigerian and British women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Ancestral links of Chesapeake Bay region African Americans to specific Bight of Bonny (West Africa) microethnic groups and increased frequency of aggressive breast cancer in both regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2173-7

10.1007/S10549-012-2173-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference